OA05914A - Procédé de préparation de nouveaux dérivés de la taurine à activité neuro-musculaire renforcée. - Google Patents

Procédé de préparation de nouveaux dérivés de la taurine à activité neuro-musculaire renforcée.

Info

Publication number
OA05914A
OA05914A OA56441A OA56441A OA05914A OA 05914 A OA05914 A OA 05914A OA 56441 A OA56441 A OA 56441A OA 56441 A OA56441 A OA 56441A OA 05914 A OA05914 A OA 05914A
Authority
OA
OAPI
Prior art keywords
enhanced
preparation
taurine derivatives
neuromuscular activity
novel
Prior art date
Application number
OA56441A
Other languages
English (en)
French (fr)
Inventor
Jean-Pierre Durlach
Original Assignee
Francaise Coop Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Francaise Coop Pharma filed Critical Francaise Coop Pharma
Publication of OA05914A publication Critical patent/OA05914A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/22—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof from sulfonic acids, by reactions not involving the formation of sulfo or halosulfonyl groups; from sulfonic halides by reactions not involving the formation of halosulfonyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA56441A 1977-03-23 1978-03-20 Procédé de préparation de nouveaux dérivés de la taurine à activité neuro-musculaire renforcée. OA05914A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7708692A FR2384751A1 (fr) 1977-03-23 1977-03-23 Nouveaux derives de la taurine a activite neuro-musculaire renforcee

Publications (1)

Publication Number Publication Date
OA05914A true OA05914A (fr) 1981-06-30

Family

ID=9188473

Family Applications (1)

Application Number Title Priority Date Filing Date
OA56441A OA05914A (fr) 1977-03-23 1978-03-20 Procédé de préparation de nouveaux dérivés de la taurine à activité neuro-musculaire renforcée.

Country Status (17)

Country Link
US (3) US4199601A (de)
JP (1) JPS53149928A (de)
AT (1) AT356637B (de)
AU (1) AU523705B2 (de)
BE (1) BE865163A (de)
CA (1) CA1095930A (de)
CH (1) CH629479A5 (de)
DE (1) DE2810918C2 (de)
ES (1) ES468201A1 (de)
FR (1) FR2384751A1 (de)
GB (1) GB1599962A (de)
GR (1) GR62093B (de)
IT (1) IT1111455B (de)
NL (1) NL7803131A (de)
OA (1) OA05914A (de)
SE (1) SE443781B (de)
ZA (1) ZA781697B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2457281A1 (fr) 1979-05-23 1980-12-19 Meram Lab Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee
US4915685A (en) * 1986-03-19 1990-04-10 Petelenz Tomasz J Methods and apparatus for iontophoresis application of medicaments at a controlled ph through ion exchange
US5602150A (en) * 1992-10-02 1997-02-11 Research Foundation For Mental Hygiene, Inc. Treatment of central nervous system disorders associated with psychotic behavior and dementia with a combination of neuroleptic drugs and taurine, or derivatives thereof, to prevent the development of tardive dyskinesia
US6099869A (en) 1995-04-18 2000-08-08 Nutrition 21 Calcium taurate and antihypertensive drug for hypertension
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
CA2319272C (en) * 1998-01-27 2005-11-08 Lipha Novel aminoalkanesulphonic, -phosphonic and -phosphinic acid derivatives, their preparation and their use as medicaments
IL146143A0 (en) * 1999-04-28 2002-07-25 Univ Kingston Compositions and methods for treating amyloidosis
US6562836B1 (en) * 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US6881750B2 (en) * 2003-03-04 2005-04-19 Nutrition Corp. Of America, Ltd. Potassium taurate bicarbonate and ascorbate
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
BRPI0517790A (pt) * 2004-11-12 2008-10-21 Neurochem Int Ltd métodos e composições fluoradas para tratar doenças relacionadas à amilóide
US20060167057A1 (en) * 2004-11-16 2006-07-27 Xianqi Kong Compounds for the treatment of CNS and amyloid associated diseases
FR2878160B1 (fr) * 2004-11-19 2008-07-25 Jean Pierre Durlach Utilisation du n-acetyl-taurinate de magnesium pour la preparation de medicaments inhibiteurs de l'hypersensiblite photique
US8044100B2 (en) * 2004-12-22 2011-10-25 Bellus Health Inc. Methods and compositions for treating amyloid-related diseases
FI3851447T3 (fi) 2006-10-12 2023-11-15 Bellus Health Inc Menetelmiä, yhdisteitä, koostumuksia ja vehikkeleitä 3-amino-1-propaanisulfonihapon vapauttamiseksi
WO2009033079A1 (en) * 2007-09-07 2009-03-12 Xenoport, Inc. Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
EP2217564A1 (de) * 2007-09-07 2010-08-18 XenoPort, Inc. Prodrugs von acamprosat mit komplexer freisetzung durch pantosäureesterneopentylsulfonylestercyclisierung, zusammensetzungen davon und anwendungsverfahren
TW200932734A (en) * 2007-10-15 2009-08-01 Xenoport Inc Internally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
FR2927809B1 (fr) * 2008-02-26 2011-01-14 Tri Inov Nouvelle utilisation de n-acetyl-taurinate de zinc.
RU2453310C1 (ru) * 2010-12-09 2012-06-20 Открытое акционерное общество "Всероссийский научный центр по безопасности биологически активных веществ" (ОАО "ВНЦ БАВ") Средство, обладающее нейропротекторным действием в условиях ишемического поражения мозга и гипоксии, представляющее собой 2-аминоэтансульфонат магния, фармацевтические композиции
FR2973702B1 (fr) 2011-04-08 2013-04-26 Tri Inov N-acetyl-taurinate de zinc pour le traitement du cancer de la prostate
ES2654554T3 (es) * 2011-11-29 2018-02-14 Basf Se Procedimiento para la preparación y la purificación de sales del ácido acrilamido-2-metil-propanosulfónico
JP6657394B2 (ja) 2015-06-17 2020-03-04 ジーン プロフェット，マーガレット ざ瘡の予防および治療のためのタウリンおよびマグネシウムを含む局所用製剤および経口用製剤
CN112353789B (zh) * 2015-12-25 2022-05-17 北京乳凝创智生物技术研发中心（有限合伙） 一种化妆品
BE1025644B1 (fr) * 2017-10-13 2019-05-15 Synapharm Industrial Synthesis Compose pour le traitement d'une maladie ou d'un trouble du systeme nerveux central chez un sujet en stimulant et/ou en restaurant la plasticite neuronale
BE1025645B1 (fr) * 2017-10-13 2019-05-15 Synapharm Industrial Synthesis Compose pour le traitement de la neurotoxicite due a l'hyperexcitabilite des recepteurs glutamatergiques ionotropes
EP3738588A1 (de) 2019-05-13 2020-11-18 Margaret Jean Profet Topische und orale formulierungen mit taurin und magnesium zur verwendung in der behandlung von rosacea
PT3738596T (pt) 2019-05-16 2022-06-02 Synapharm Ind Synthesis Composto e composição para utilização no tratamento da síndrome pré-menstrual e/ou distúrbio disfórico pré-menstrual
CA3137407A1 (fr) 2019-05-16 2020-11-19 Synapharm Industrial Synthesis Compound and composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder
BE1026955B1 (fr) * 2019-06-11 2020-08-04 Synapharm Ind Synthesis Procédé de fabrication de N-acétyl-taurinate de magnésium
RU2731106C1 (ru) * 2019-10-23 2020-08-28 Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ Дикалиевая соль N-(4-гидроксибензоил)таурина, обладающая антиагрегантной и антитромботической активностью
RU2730835C1 (ru) * 2019-10-23 2020-08-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ Дикалиевая соль N-(3-гидроксибензоил)таурина, обладающая антиагрегантной и антитромботической активностью в сочетании с церебропротективным действием
WO2021245697A1 (en) 2020-06-01 2021-12-09 Celagenex Research (India) Pvt. Ltd. Novel synergistic medicinal compositions for treating dysfunctional d-serine signaling

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232968A (en) * 1959-12-01 1966-02-01 Gen Aniline & Film Corp Process for preparing n-acyl taurates using hypophosphorous acid as catalyst
US3344174A (en) * 1962-08-21 1967-09-26 Monsanto Co Vicinal acylamido sulfonate compounds
DE1256650B (de) * 1965-08-07 1967-12-21 Dr Dieter Arlt Verfahren zur Herstellung von N-acylierten 2-Amino-alkan-sulfonsaeuren-(1) bzw. von 2-Amino-alkan-sulfonsaeuren-(1)
US3544597A (en) * 1969-06-12 1970-12-01 Rohm & Haas Process for manufacturing sulfonated amides
US3960918A (en) * 1973-06-26 1976-06-01 The Lubrizol Corporation Preparation of esters of amidoalkanesulfonic acids

Also Published As

Publication number Publication date
JPS53149928A (en) 1978-12-27
DE2810918C2 (de) 1985-06-20
AU523705B2 (en) 1982-08-12
SE443781B (sv) 1986-03-10
ES468201A1 (es) 1978-12-01
AT356637B (de) 1980-05-12
ZA781697B (en) 1979-03-28
BE865163A (fr) 1978-09-22
US4271189A (en) 1981-06-02
ATA202878A (de) 1979-10-15
GB1599962A (en) 1981-10-07
US4199601A (en) 1980-04-22
SE7803032L (sv) 1978-09-24
IT7867631A0 (it) 1978-03-22
CA1095930A (en) 1981-02-17
CH629479A5 (fr) 1982-04-30
JPS6256867B2 (de) 1987-11-27
NL7803131A (nl) 1978-09-26
US4267194A (en) 1981-05-12
IT1111455B (it) 1986-01-13
FR2384751B1 (de) 1979-07-20
FR2384751A1 (fr) 1978-10-20
DE2810918A1 (de) 1978-09-28
GR62093B (en) 1979-02-22
AU3463478A (en) 1979-10-04

Similar Documents

Publication Publication Date Title
OA05914A (fr) Procédé de préparation de nouveaux dérivés de la taurine à activité neuro-musculaire renforcée.
OA05444A (fr) Procédé de préparation de nouveaux dérivés benzhydrylsulfinyle.
OA05928A (fr) Nouveaux dérivés de céphalosporine, leur procédé de préparation.
OA05939A (fr) Dérivés de céphalosporine et leur procédé de préparation.
OA05022A (fr) Procédé de préparation de nouveaux dérivés de benzothiophène.
OA04868A (fr) Dérivés de 2-acyl-4-oxo-pyrazino-isoquinoléine et leur procédé de préparation.
OA05725A (fr) Procédé de préparation de dérivés d'acides hydroxy-aminophosphonique hydrocarbonés.
OA05630A (fr) Nouveaux dérivés phénoxybenzyloxycarbonyliques substitués, leur procédé de préparation et leur application comme insecticides et acaricides.
OA07766A (fr) Procédé de préparation de dérivés de cephème.
RO79732A (ro) Procedeu pentru prepararea unor 7-acilaminofenil-etanolamine
OA06811A (fr) Procédé de préparation de nouveaux dérivés de pyridoxine.
OA05445A (fr) Procédé de préparation de nouvelles pyrimidones.
OA05895A (fr) Nouveaux dérivés de la pyrrolidine, leur procédé de préparation et leur application en thérapeutique.
OA06105A (fr) Dérivés antithéilériaux de naphthoquinone.
OA05385A (fr) Procédé de préparation de nouveaux dérivés phénoxy.
OA05405A (fr) Procédé de préparation de composés pharmacologiquement actifs.
OA06122A (fr) Procédé de préparation d'un nouveau dérivé de pyridine.
OA05605A (fr) Procédé de préparation de nouvelles isobutyramides.
OA05350A (fr) Nouveaux benzamides substtitués, leurs dérivés et leur procédé de préparation.
OA05260A (fr) Procédé de préparation de dérivés d'histidine.
OA05485A (fr) Procédé de préparation de nouveaux dérivés hétérocycliques.
OA05404A (fr) Procédé de préparation de composés pharmocologiquement actifs.
FR2314192A1 (fr) Procede de preparation d'oxaphospholannes-1,2
OA05675A (fr) Procédé de préparation de dérivés de méthylamine.
OA05295A (fr) Procédé de préparation de tétrazoles substitués.